Early-stage cancer detection, powered by the microbiome



Micronoma is the first cancer-detection company utilizing signals from some of the most ancient matter in the world, microbial nucleic acids, to empower clinicians to diagnose cancer at an early stage with minimally invasive, microbiome-driven liquid biopsy technology. Micronoma was founded in 2019 by leaders in microbiome research with the goal of revolutionizing and advancing the practice of early cancer diagnostics and personalized treatment through sensitive microbiome techniques, ensuring that patients’ needs are identified and addressed by their clinicians at the earliest stage for a better chance to live longer, healthier lives. The company is headquartered in San Diego, California.

Bios and Headshots

Sandrine Miller-Montgomery
Pharm. D., Ph.D.

Co-Founder, Board Member
President, and CEO

Greg Poore, Ph,D.

Co-Founder, Board Member
Chief Analytics Officer,
Oncobiota TM Co-Inventor

Rob Knight, Ph,D.

Co-Founder and Scientific
Advisory Board Member
Oncobiota TM Co-Inventor



Celia Sepulveda
(858) 337-1326

Website Terms of Use, Privacy Policy, and Licenses and Accreditations

Micronoma, INC., CLIA #05D2253538

Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.

6342 Ferris Square
San Diego, CA 92121